Prelude Capital Management, LLC Spectrum Pharmaceuticals Inc Transaction History

Prelude Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.65 - $1.31 $30,477 - $61,424	46,889 New	46,889 $45,000
Q4 2020 Feb 16, 2021	SELL	$3.38 - $5.14 $42,851 - $65,164	-12,678 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $7,040 - $13,272	3,847 Added 43.56%	12,678 $30,000
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $30,908 - $91,400	8,831 New	8,831 $32,000
Q2 2019 Aug 14, 2019	SELL	$7.36 - $11.26 $5,424 - $8,298	-737 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $199 - $260	22 Added 3.08%	737 $8,000
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $149,110 - $396,461	-23,335 Reduced 97.03%	715 $6,000
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $380,786 - $572,101	23,050 Added 2305.0%	24,050 $404,000
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $14,310 - $21,750	1,000 New	1,000 $21,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.